Class Action Lawsuit Filed Against Unicycive Therapeutics: Investors Urged to Act

Class Action Lawsuit Against Unicycive Therapeutics, Inc.

In a significant legal development, a class action lawsuit has been initiated against Unicycive Therapeutics, Inc. (NASDAQ: UNCY) by Levi & Korsinsky, LLP. This lawsuit comes as a measure to protect investors who believe they may have incurred losses due to securities fraud in the company.

Background of the Case

The lawsuit specifically targets investors who were affected by events during the time period spanning from March 29, 2024, to June 27, 2025. It claims that Unicycive Therapeutics made misleading statements regarding its capabilities and regulatory processes, particularly in relation to satisfying the manufacturing compliance requirements set forth by the FDA.

According to the filed allegations, Unicycive overestimated its readiness and ability to fulfill regulatory obligations concerning its drug application for oxylanthanum carbonate. Such misrepresentations have led to a perceived stability in the company's public image that was, in fact, unfounded.

What Investors Should Know

Investors of Unicycive Therapeutics are urged to assess whether they qualify for participation in this class action lawsuit. Those who believe they have suffered financial harm because of the company's deceptive practices should take action. Notably, the deadline for investors to request the appointment as lead plaintiff is set for October 14, 2025.

It's crucial to recognize that participating in the lawsuit does not necessitate serving as a lead plaintiff; any eligible class member can benefit from the outcome of this action. Moreover, there are no out-of-pocket costs associated with joining the lawsuit, which assures that investors can seek restitution without incurring additional financial burdens.

Levi & Korsinsky's Role

The law firm Levi & Korsinsky has a robust history in securities litigation, known for securing substantial settlements for aggrieved shareholders. Over two decades, they have garnered a reputation for effectively representing investors, as highlighted by their ranking in ISS Securities Class Action Services' Top 50 Report for seven consecutive years. Their experienced team of attorneys remains dedicated to delivering justice to investors who have endured losses due to corporate misdeeds.

How to Proceed

Affected investors are encouraged to reach out directly to Levi & Korsinsky. Joseph E. Levi, Esq. and Ed Korsinsky, Esq. can be contacted at their New York office via email or phone for further guidance on the next steps. The firm has also provided resources online to facilitate the joining of this legal action.

For more information and to ensure you do not miss this critical opportunity, visit the following link: Levi & Korsinsky Unicycive Lawsuit Information

Investors have the chance to reclaim their losses through this collective legal action. As the situation develops, staying informed and taking prompt action will be paramount for those who have been impacted by Unicycive’s alleged actions.